Dante Mário Langhi

784 total citations
53 papers, 463 citations indexed

About

Dante Mário Langhi is a scholar working on Hematology, Biochemistry and Physiology. According to data from OpenAlex, Dante Mário Langhi has authored 53 papers receiving a total of 463 indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Hematology, 14 papers in Biochemistry and 12 papers in Physiology. Recurrent topics in Dante Mário Langhi's work include Blood groups and transfusion (17 papers), Blood transfusion and management (14 papers) and Erythrocyte Function and Pathophysiology (12 papers). Dante Mário Langhi is often cited by papers focused on Blood groups and transfusion (17 papers), Blood transfusion and management (14 papers) and Erythrocyte Function and Pathophysiology (12 papers). Dante Mário Langhi collaborates with scholars based in Brazil, United States and Canada. Dante Mário Langhi's co-authors include José Orlando Bordin, Carlos Chiattone, Rodolfo Delfini Cançado, Gil Cunha De Santis, José Francisco Comenalli Marques, Hélio Moraes‐Souza, Akemi Kuroda Chiba, Dimas Tadeu Covas, W. Beau Mitchell and Alfredo Mendrone and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and British Journal of Haematology.

In The Last Decade

Dante Mário Langhi

44 papers receiving 449 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dante Mário Langhi Brazil 12 218 125 89 73 69 53 463
Patricia A. R. Brunker United States 9 92 0.4× 48 0.4× 34 0.4× 58 0.8× 24 0.3× 26 257
Elizabeth H. Perry United States 15 266 1.2× 80 0.6× 28 0.3× 14 0.2× 84 1.2× 21 611
Denise Menezes Brunetta Brazil 11 171 0.8× 158 1.3× 22 0.2× 20 0.3× 26 0.4× 36 379
Vincenzo De Angelis Italy 12 85 0.4× 26 0.2× 26 0.3× 40 0.5× 25 0.4× 35 336
Isabelle Mendel France 10 54 0.2× 29 0.2× 17 0.2× 60 0.8× 16 0.2× 13 408
Irene T.M. Lindenburg Netherlands 14 493 2.3× 179 1.4× 241 2.7× 5 0.1× 27 0.4× 20 704
John M. Bowman Canada 13 454 2.1× 134 1.1× 190 2.1× 6 0.1× 31 0.4× 35 705
Elizabeth B. Hafleigh United States 6 185 0.8× 35 0.3× 57 0.6× 20 0.3× 10 0.1× 8 509
Julie Curtin Australia 17 421 1.9× 104 0.8× 21 0.2× 4 0.1× 42 0.6× 42 770
L. Nilsson Sweden 12 86 0.4× 43 0.3× 14 0.2× 32 0.4× 134 1.9× 21 660

Countries citing papers authored by Dante Mário Langhi

Since Specialization
Citations

This map shows the geographic impact of Dante Mário Langhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dante Mário Langhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dante Mário Langhi more than expected).

Fields of papers citing papers by Dante Mário Langhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dante Mário Langhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dante Mário Langhi. The network helps show where Dante Mário Langhi may publish in the future.

Co-authorship network of co-authors of Dante Mário Langhi

This figure shows the co-authorship network connecting the top 25 collaborators of Dante Mário Langhi. A scholar is included among the top collaborators of Dante Mário Langhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dante Mário Langhi. Dante Mário Langhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Benites, Bruno Deltreggia, et al.. (2024). Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management. Hematology Transfusion and Cell Therapy. 46. S24–S31.
3.
Marques, José Francisco Comenalli, et al.. (2024). Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management. Hematology Transfusion and Cell Therapy. 46. S8–S11.
4.
Rodrigues, Roseny dos Reis, et al.. (2024). Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management. Hematology Transfusion and Cell Therapy. 46. S53–S59.
5.
Oliveira, Luciana Correa Oliveira de, et al.. (2024). Consensus of the Brazilian association of hematology, hemotherapy and cellular therapy on patient blood management. Hematology Transfusion and Cell Therapy. 46. S48–S52.
6.
Mendrone, Alfredo, et al.. (2022). Development and implementation of a COVID-19 convalescent plasma program in a middle-income economy. Hematology Transfusion and Cell Therapy. 44(2). 206–212. 1 indexed citations
7.
Bordin, José Orlando, et al.. (2022). Targeting patient blood management's first pillar: A multicentric retrospective study on preoperative anemia. Hematology Transfusion and Cell Therapy. 45(3). 338–341.
8.
Chiba, Akemi Kuroda, et al.. (2021). Serologic and molecular studies to identify neonatal alloimmune neutropenia in a cohort of 10,000 neonates. British Journal of Haematology. 192(4). 778–784. 4 indexed citations
9.
Santis, Gil Cunha De, et al.. (2021). Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VI: Accreditation process. Hematology Transfusion and Cell Therapy. 43. S42–S45. 1 indexed citations
10.
Santis, Gil Cunha De, Dante Mário Langhi, Alfredo Mendrone, et al.. (2021). Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. V: Manufacture and quality control. Hematology Transfusion and Cell Therapy. 43. S35–S41. 1 indexed citations
11.
Oliveira, Luciana Correa Oliveira de, Benedito Antônio Lopes da Fonseca, Maria Auxiliadora‐Martins, et al.. (2021). Histo‐blood group A is a risk factor for severe COVID‐19. Transfusion Medicine. 32(3). 248–251. 10 indexed citations
12.
Langhi, Dante Mário, Gil Cunha De Santis, & José Orlando Bordin. (2020). COVID-19 convalescent plasma transfusion. Hematology Transfusion and Cell Therapy. 42(2). 113–115. 22 indexed citations
13.
Chiba, Akemi Kuroda, et al.. (2018). Molecular study of Cw/Cx antigens and frequency of Rh phenotypes in southeast Brazilian blood donors. Journal of Clinical Laboratory Analysis. 32(8). e22570–e22570. 1 indexed citations
14.
Chiba, Akemi Kuroda, et al.. (2018). Antibodies to human neutrophil antigen HNA‐3b implicated in cases of neonatal alloimmune neutropenia. Transfusion. 58(5). 1264–1270. 11 indexed citations
15.
Klautau, Giselle Burlamaqui, et al.. (2018). Prevalência da infecção pelo vírus Epstein-Barr em voluntários doadores de sangue e indivíduos com AIDS na cidade de São Paulo. LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas). 2 indexed citations
17.
Martins, Paulo Roberto Juliano, et al.. (2012). Alloimmunization screening after transfusion of red blood cells in a prospective study. SHILAP Revista de lepidopterología. 34(3). 206–211. 42 indexed citations
18.
Cançado, Rodolfo Delfini & Dante Mário Langhi. (2012). Blood donation, blood supply, iron deficiency and anemia - It is time to shift attention back to donor health. SHILAP Revista de lepidopterología. 34(5). 330–331. 6 indexed citations
19.
Langhi, Dante Mário, et al.. (2009). Urgência na introdução do NAT: é fundamental não cometer os erros do passado. Revista Brasileira de Hematologia e Hemoterapia. 31(2). 2 indexed citations
20.
Chiattone, Carlos, et al.. (2008). Urgência na introdução do NAT: é fundamental não cometer os erros do passado. Revista Brasileira de Hematologia e Hemoterapia. 30(4). 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026